The classic website will no longer be available as of June 25, 2024. Please use the modernized
Working… Menu

Neoadjuvant Tremelimumab and Durvalumab With Gem/Cis in Intrahepatic Cholangiocarcinoma (ESR-22-21719)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT06017297
Recruitment Status : Recruiting
First Posted : August 30, 2023
Last Update Posted : April 24, 2024
Information provided by (Responsible Party):
Georgetown University

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 2026
Estimated Study Completion Date : November 2026